12.06.2019 • NewsDede WillamsKeytrudaUS Merck

Keytruda Wins two new Cancer Approvals

Keytruda Wins two new Cancer Approvals
Keytruda Wins two new Cancer Approvals

Keytruda, the multi-indication oncology drug manufactured by US Merck & Co, has won approval from the Food and Drug Administration (FDA) for both monotherapy and combination therapy in previously untreated head and neck cancer.

With the green light, Keytruda becomes the first in its class of PD-1/PD-L1 drugs to be used in this indication.

The monotherapy indication covers patients whose tumors bear the biomarker PD-L1. In the combination variation it is matched with a commonly used chemotherapy regimen in patients, regardless of PD-L1 status.

The FDA’s green light follows a fast-track review agreed in February of this year after data from Phase 3 trials showed that, when compared with a certain standard treatment, Keytruda could lower the risk of death by 22% in PD-L1 positive patients.

When combined with a commonly used chemotherapy regimen, the Merck drug was shown to slash the risk of death by 23% regardless of patients’ PD-L1 status.

The US drugmaker said 65,000 patients with head and neck cancers could potentially profit from access to Keytruda

Merck’s new Keytruda indication puts it ahead of Bristol-Myers Squibb, whose Opdivo treatment is approved only for patients who have already failed on chemotherapy.

The trade journal Fierce Pharma points out that BMS has already ceded the lead in lung cancer, immuno-oncology’s most lucrative market, to Keytruda. In kidney cancer, an area historically important to Opdivo sales, Merck recently won approval for  competing combination treatment.

Interview

Specialty Chemicals in a Shifting World
Adapting to Tariffs and Strengthening Regional Networks

Specialty Chemicals in a Shifting World

Jennifer Abril, President & CEO of SOCMA, discusses the impact of new tariffs and the importance of regional supply networks in the specialty chemical industry.

Free Virtual Event

Sustainability in Bioprocessing
Bioprocess Forum

Sustainability in Bioprocessing

Join us to explore hot topics in sustainable bioprocessing like the industrial potential of enzymatic synthesis, innovative biocatalysis techniques, and the use of digital twins in bioprocessing.